Pyxis Oncology, Inc. Share Price: PYXS (Pyxis Oncology, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Pyxis Oncology, Inc. share price today?

Accepted Answer

Pyxis Oncology, Inc. (PYXS) share price today is {{live_price}}.

Question 2

Can Indians buy Pyxis Oncology, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Pyxis Oncology, Inc. (PYXS) from India.

With INDmoney, you can buy Pyxis Oncology, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Pyxis Oncology, Inc. at zero transaction cost.

Question 3

How can I buy Pyxis Oncology, Inc. shares from India?

Accepted Answer

It is very easy to buy Pyxis Oncology, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Pyxis Oncology, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Pyxis Oncology, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Pyxis Oncology, Inc. stocks?

Accepted Answer

To start investing in Pyxis Oncology, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Pyxis Oncology, Inc.

Accepted Answer

Today’s highest price of Pyxis Oncology, Inc. (PYXS) is {{1_rba_end}}.

Today’s lowest price of Pyxis Oncology, Inc. (PYXS) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Pyxis Oncology, Inc.

Accepted Answer

Today's market capitalisation of Pyxis Oncology, Inc. PYXS is 272.6M

Question 8

What is the 52 Week High and Low Range of Pyxis Oncology, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Pyxis Oncology, Inc. is down from its 52 Week High?

Accepted Answer

Pyxis Oncology, Inc. (PYXS) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Pyxis Oncology, Inc. is up from its 52 Week low?

Accepted Answer

Pyxis Oncology, Inc. (PYXS) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Pyxis Oncology, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Pyxis Oncology, Inc.

Accepted Answer

Mr. John L. Flavin M.B.A., MBA, Ph.D. is the current Chief Executive Officer (CEO) of Pyxis Oncology, Inc..

Period	Pyxis Oncology, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	122.07%	-0.7%	0.0%
6 Months	172.88%	6.6%	0.0%
1 Year	56.82%	3.7%	-1.5%
3 Years	-63.41%	14.0%	-21.8%

Market Capitalization	272.6M
Book Value	$2.81
Earnings Per Share (EPS)	-1.85
Wall Street Target Price	8.0

Profit Margin	0.0%
Operating Margin TTM	0.0%

Return On Assets TTM	-26.1%
Return On Equity TTM	-51.51%

Revenue TTM	0.0
Revenue Per Share TTM	0.0
Quarterly Revenue Growth YOY	0.0%
Gross Profit TTM	0.0
EBITDA	-78.5M
Diluted Eps TTM	-1.85
Quarterly Earnings Growth YOY	0.0

Pyxis Oncology, Inc. (PYXS)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Institutional Holdings

Corporate Announcements

Pyxis Oncology, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-0.91
EPS Estimate Next Year	-1.2
EPS Estimate Current Quarter	-0.47
EPS Estimate Next Quarter	-0.34

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Pyxis Oncology, Inc.	-1.43%	172.88%	56.82%	-63.41%	-63.41%
Moderna, Inc.	-0.79%	20.27%	-27.48%	-36.11%	359.53%
Regeneron Pharmaceuticals, Inc.	-6.12%	9.1%	11.53%	80.35%	170.35%
Novo Nordisk A/s	-6.29%	23.82%	46.7%	242.59%	414.69%
Vertex Pharmaceuticals Incorporated	-4.44%	6.95%	20.9%	79.35%	133.77%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Pyxis Oncology, Inc.	NA	NA	NA	-0.91	-0.52	-0.26	NA	2.81
Moderna, Inc.	24.73	NA	0.0	-7.22	-0.29	-0.12	NA	36.27
Regeneron Pharmaceuticals, Inc.	25.71	25.71	1.46	45.13	0.16	0.08	NA	242.47
Novo Nordisk A/s	46.58	46.58	2.4	3.33	0.88	0.23	0.01	23.9
Vertex Pharmaceuticals Incorporated	28.42	28.42	0.53	16.73	0.23	0.13	NA	68.22

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Pyxis Oncology, Inc.	Buy	$272.6M	-63.41%	NA	0.0%
Moderna, Inc.	Buy	$39.8B	359.53%	24.73	-68.84%
Regeneron Pharmaceuticals, Inc.	Buy	$98.1B	170.35%	25.71	30.14%
Novo Nordisk A/s	Buy	$551.2B	414.69%	46.58	36.03%
Vertex Pharmaceuticals Incorporated	Buy	$101.9B	133.77%	28.42	36.68%

Organization	Pyxis Oncology, Inc.
Employees	50
CEO	Mr. John L. Flavin M.B.A., MBA, Ph.D.
Industry	Healthcare